Maze Therapeutics, Inc. Common Stock MAZE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$24.21M+30.0% | -$34.57M-14.9% | -$30.09M+10.7% | -$33.68M-2.7% | -$32.79M— | ||
| $444K-11.0% | $499K-12.6% | $571K-12.0% | $649K-5.1% | $684K-3.0% | ||
| $7.11M+17.1% | $6.07M+57.2% | $3.86M+19.4% | $3.24M+0.3% | $3.23M+13.2% | ||
| -$39.11M-41.0% | -$27.73M-12.5% | -$24.64M+18.0% | -$30.05M-1.8% | -$29.52M— | ||
| $93K+174% | $34K-50.0% | $68K-82.7% | $393K+31.4% | $299K-50.6% | ||
| $6.28M+106% | -$103.39M-54.6% | -$66.88M-16,919% | -$393K-31.4% | -$299K+50.6% | ||
| $39.4M— | —— | —— | —— | —— | ||
| $42.36M+1,080% | $3.59M-97.5% | $143.76M+23,390% | $612K-99.5% | $127.38M+81.3% | ||
| $9.52M+107% | -$127.53M-344% | $52.23M+275% | -$29.83M-131% | $97.56M+107% | ||
| -$39.21M-41.2% | -$27.76M-12.4% | -$24.71M+18.8% | -$30.45M-2.1% | -$29.82M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maze Therapeutics, Inc. Common Stock generate?
- Maze Therapeutics, Inc. Common Stock (MAZE) generated -$121.5M in operating cash flow over the trailing twelve months.
- What is Maze Therapeutics, Inc. Common Stock's free cash flow?
- After $588.0K of capital expenditures, Maze Therapeutics, Inc. Common Stock's free cash flow was -$122.1M over the trailing twelve months.
- Where does Maze Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Maze Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
